Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,742,054
+$1,284,283 QoQ
Shares Held
153,813
-3.9% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 230 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. RCUS ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in RCUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,742,054 | 153,813 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,457,771 | 160,082 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,383,506 | 225,913 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,854,055 | 209,857 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,265,729 | 155,495 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,260,223 | 160,538 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $23,043,629 | 1,547,591 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,171,576 | 1,319,266 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,455,688 | 1,474,438 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,675,275 | 1,201,021 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $31,224,775 | 1,634,805 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $28,359,634 | 1,579,924 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $30,018,097 | 1,477,996 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,557,438 | 195,035 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $4,220,829 | 204,102 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,468,957 | 209,058 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,875,238 | 192,393 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $10,405,555 | 298,410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,194,337 | 298,410 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $38,480,690 | 1,370,395 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,731,162 | 1,376,393 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||